HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Spatially resolved analyses link genomic and immune diversity and reveal unfavorable neutrophil activation in melanoma.

Abstract
Complex tumor microenvironmental (TME) features influence the outcome of cancer immunotherapy (IO). Here we perform immunogenomic analyses on 67 intratumor sub-regions of a PD-1 inhibitor-resistant melanoma tumor and 2 additional metastases arising over 8 years, to characterize TME interactions. We identify spatially distinct evolution of copy number alterations influencing local immune composition. Sub-regions with chromosome 7 gain display a relative lack of leukocyte infiltrate but evidence of neutrophil activation, recapitulated in The Cancer Genome Atlas (TCGA) samples, and associated with lack of response to IO across three clinical cohorts. Whether neutrophil activation represents cause or consequence of local tumor necrosis requires further study. Analyses of T-cell clonotypes reveal the presence of recurrent priming events manifesting in a dominant T-cell clonotype over many years. Our findings highlight the links between marked levels of genomic and immune heterogeneity within the physical space of a tumor, with implications for biomarker evaluation and immunotherapy response.
AuthorsAkash Mitra, Miles C Andrews, Whijae Roh, Marianna Petaccia De Macedo, Courtney W Hudgens, Fernando Carapeto, Shailbala Singh, Alexandre Reuben, Feng Wang, Xizeng Mao, Xingzhi Song, Khalida Wani, Samantha Tippen, Kwok-Shing Ng, Aislyn Schalck, Donald A Sakellariou-Thompson, Eveline Chen, Sangeetha M Reddy, Christine N Spencer, Diana Wiesnoski, Latasha D Little, Curtis Gumbs, Zachary A Cooper, Elizabeth M Burton, Patrick Hwu, Michael A Davies, Jianhua Zhang, Chantale Bernatchez, Nicholas Navin, Padmanee Sharma, James P Allison, Jennifer A Wargo, Cassian Yee, Michael T Tetzlaff, Wen-Jen Hwu, Alexander J Lazar, P Andrew Futreal
JournalNature communications (Nat Commun) Vol. 11 Issue 1 Pg. 1839 (04 15 2020) ISSN: 2041-1723 [Electronic] England
PMID32296058 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Biomarkers, Tumor
Topics
  • Biomarkers, Tumor (genetics)
  • DNA Copy Number Variations (genetics)
  • Genomics (methods)
  • Humans
  • Melanoma (genetics, metabolism)
  • Mutation (genetics)
  • Neutrophil Activation (genetics, physiology)
  • Tumor Microenvironment (genetics, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: